State Street Corp Neuro Bo Pharmaceuticals, Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.72 - $1.54 $489 - $1,047	680 Added 4.28%	16,558 $15,000
Q2 2021 Aug 16, 2021	SELL	$2.74 - $4.63 $159,424 - $269,391	-58,184 Reduced 78.56%	15,878 $53,000
Q1 2021 May 17, 2021	BUY	$3.93 - $6.68 $108,880 - $185,069	27,705 Added 59.76%	74,062 $326,000
Q4 2020 Feb 16, 2021	BUY	$5.02 - $6.59 $24,688 - $32,409	4,918 Added 11.87%	46,357 $243,000
Q3 2020 Nov 10, 2020	BUY	$5.41 - $8.67 $15,294 - $24,510	2,827 Added 7.32%	41,439 $233,000
Q2 2020 Aug 14, 2020	BUY	$8.05 - $29.44 $310,826 - $1.14 Million	38,612 New	38,612 $311,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.